Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
73.1M
-
Number of holders
-
94
-
Total shares
-
4.86M
-
Shares change
-
+1.02M
-
Total reported value, excl. options
-
$17.8M
-
Value change
-
+$3.77M
-
Put/Call ratio
-
0.16
-
Number of buys
-
36
-
Number of sells
-
-26
-
Price
-
$3.66
Significant Holders of Mind Medicine (MindMed) Inc. - Common Stock (MNMD) as of Q4 2023
100 filings reported holding MNMD - Mind Medicine (MindMed) Inc. - Common Stock as of Q4 2023.
Mind Medicine (MindMed) Inc. - Common Stock (MNMD) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.86M shares
of 73.1M outstanding shares and own 6.65% of the company stock.
Largest 10 shareholders include Ikarian Capital, LLC (600K shares), VANGUARD GROUP INC (568K shares), BlackRock Inc. (551K shares), GEODE CAPITAL MANAGEMENT, LLC (378K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (230K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (192K shares), Busey Bank (156K shares), Cresset Asset Management, LLC (154K shares), BOOTHBAY FUND MANAGEMENT, LLC (147K shares), and TWO SIGMA INVESTMENTS, LP (139K shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.